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Abstract
Protein-energy wasting (PEW) is highly prevalent in peritoneal dialysis (PD) patients and 
is associated with mortality. Reduced protein and energy intake, comorbidity conditions, 
endocrine disorders, increased inflammatory cytokines, uremic toxins, metabolic acido-
sis, oxidative stress, nutrient losses into dialysate, continuous absorption of glucose from 
PD solutions, abdominal fullness induced by the dialysate, and peritonitis contribute to 
PEW. Assessment of nutritional status for the detection and management of PEW includes 
the PEW definition criteria, subjective global assessment (SGA), malnutrition-inflamma-
tion score (MIS), and geriatric nutritional risk index (GNRI). Diverse factors can affect 
nutritional and metabolic status in these patients so multiple strategies may be required to 
prevent or reverse PEW. Preventive measures include continuous nutritional counseling, 
optimizing dietary nutrient intake, and managing comorbidities. To treat PEW, the follow-
ing may be used: administration of oral, intraperitoneal, enteral, or parenteral nutritional 
supplementation and adjunct therapies such as anabolic agents, appetite stimulants, anti-
inflammatory interventions, and exercise. Diagnosis, prevention, and treatment of PEW in 
PD patients may favorably impact the prognosis and course of the disease.
Keywords: protein-energy wasting, peritoneal dialysis, nutritional assessment,  
protein-energy wasting definition criteria, subjective global assessment,  
malnutrition-inflammation score, geriatric nutritional risk index
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1. Introduction
End-stage renal disease (ESRD) represents a serious public health problem in Mexico. It has 
been reported among the ten primary causes of death in the country with an annual mortal-
ity of 12.3 deaths per 100,000 people and is the second cause of years of life lost. The annual 
incidence is 421 persons per million population (pmp) with a prevalence of 1568 pmp. It is 
estimated that 8.5% of the Mexican population has chronic kidney disease (CKD) and almost 
65,000 patients undergo dialysis. Peritoneal dialysis (PD) was introduced in Mexico in the 
early 1980s, and it became the renal replacement therapy of choice that rapidly extended 
to the population with social security coverage, as well as the uninsured population: the 
use of PD is the first choice in treatment when there is inadequate access to other meth-
ods like hemodialysis and renal transplant, and so the number of PD patients continues to 
rise [1, 2]. Despite the progressive rise in the use of hemodialysis in Mexico for some years 
now [1], when compared to other countries, Mexico continues to be one of the countries in 
the world where more PD is used [2, 3]. One of the most serious complications of CKD is 
protein-energy wasting (PEW), and this has an important therapeutic challenge because of 
its frequency in patients with ESRD who receive dialysis [4]. Therefore, from an integrated 
standpoint, this chapter reviews the diagnosis, prevention, and treatment of PEW in PD 
patients.
2. Protein-energy wasting
A variety of terms and definitions have been used to describe the conditions associated with 
loss of the muscle and fat tissue, malnutrition, and inflammation in patients with CKD, which 
have been denominated: uremic malnutrition, uremic (renal) cachexia, protein-energy malnu-
trition, malnutrition-inflammation-atherosclerosis syndrome, or malnutrition-inflammation 
complex (or cachexia) syndrome. The use of nonuniform and ill-defined terminologies may 
lead to both conceptual errors and malinterpretation of the data [5]. Therefore, the panel of 
experts of the International Society of Renal Nutrition and Metabolism (ISRNM) proposed 
the term “protein-energy wasting” as the state in which a decline in the body stores of protein 
1. Decreased protein and energy intake
a. Anorexia
i. Dysregulation in circulating appetite mediators
ii. Hypothalamic amino acid sensing
iii. Nitrogen-based uremic toxins
b. Dietary restrictions
c. Alterations in organs involved in nutrient intake
d. Depression
e. Inability to obtain or prepare food
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and energy fuels (i.e., body protein and fat masses) presents due to the multiple nutritional 
and catabolic alterations that occur in CKD [5, 6]. These alterations include a decrease in 
the protein and energy intake, comorbidity conditions, endocrine disorders, an increase in 
the production of inflammatory cytokines, uremic toxins, metabolic acidosis, oxidative stress, 
and the nutrient losses into dialysate, among others (Table 1) [5, 6]. PD itself can lead to 
PEW due to the continuous absorption of glucose from PD solutions, the abdominal fullness 
induced by the dialysate, and peritonitis that can suppress the appetite [7]. Cachexia occurs 
infrequently in kidney disease, and it is the most severe form of PEW since the latter can refer 
to mild degrees of depleted protein and energy mass [5].
2. Hypermetabolism
a. Increased energy expenditure
i. Inflammation
ii. Increased circulating proinflammatory cytokines
iii. Insulin resistance secondary to obesity
iv. Altered adiponectin and resistin metabolism
b. Hormonal disorders
i. Insulin resistance of CKD
ii. Increased glucocorticoid activity
3. Metabolic acidosis
4. Decreased physical activity
5. Decreased anabolism
a. Decreased nutrient intake
b. Resistance to growth hormone/insulin-like growth factor-1
c. Testosterone deficiency
d. Low thyroid hormone levels
6. Comorbidities and lifestyle
a. Comorbidities (diabetes mellitus, congestive heart failure, depression, coronary artery disease, peripheral 
vascular disease)
7. Dialysis
a. Nutrient losses into dialysate
b. Dialysis-related inflammation
c. Dialysis-related hypermetabolism
d. Loss of residual renal function
Table 1. Causes of PEW in CKD patients.
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3. Prevalence of protein-energy wasting
PEW has been reported in PD patients in a wide range that goes from 23 to 90%, and the 
prevalence of PEW varies depending on the definitions used and the origin of the population 
[8–15]. In Mexico, the prevalence fluctuates between 49 and 92% in the prevalent as well as 
the incidental population in distinct PD programs [16]. This is a serious problem since PEW is 
associated with mortality in these patients [8].
4. Assessment of protein-energy wasting
Assessment and monitoring of the nutritional status is important to diagnose, prevent, and 
treat PEW [17]. Nutritional tools like the PEW definition criteria, subjective global assessment 
(SGA), malnutrition-inflammation score (MIS), and geriatric nutritional risk index (GNRI) 
have been widely recommended [18].
4.1. Protein-energy wasting definition criteria
The expert panel of the ISRNM has recommended diagnostic criteria for PEW that include (1) 
serum chemistry (albumin, prealbumin, cholesterol), (2) body mass (body mass index-BMI), 
unintentional weight loss, total body fat percentage), (3) muscle mass (muscle wasting, reduced 
mid-arm muscle circumference-MAMC, creatinine appearance), and (4) dietary intake (low 
protein or energy intake) (Table 2). At least three out of the four listed categories (and at least 
one test in each of the selected category) must be satisfied for the diagnosis of PEW. Optimally, 
each criterion should be documented on at least three occasions, preferably 2–4 weeks apart [5].
4.1.1. Serum chemistry
The reduction in serum albumin levels is a strong predictor of mortality in PD patients [8, 
19, 20]. Also, it is one of the most used biochemical criteria in the diagnosis of PEW [21]. 
However, as a nutritional parameter, it should be interpreted with caution because its half-life 
is approximately 20 days and can be affected by inflammation, losses into dialysate, and the 
volume state [7]. Our research group has reported that serum albumin levels are not associated 
between patients with and without incidents of PEW in PD [21]. On the other hand, the half-
life of approximately 2 days makes the prealbumin or transthyretin a more sensitive marker 
for nutritional status than serum albumin [7]. The levels of prealbumin of <30 mg/dL have 
been observed to increase the risk of mortality [22, 23]. The value of the prealbumin as a nutri-
tional biochemical predictor of greater survival has been confirmed [22–24]. Another proposed 
biochemical marker is cholesterol. Low levels of cholesterol have been associated with worse 
results in this population [25, 26], and this diagnostic criterion is among the most controversial 
for PEW because the low level as a result of diet and exercise might not reflect PEW [27].
4.1.2. Body mass
Among the indicators of body mass, the BMI is the most commonly used measurement of 
weight-for-height and can be applied to assess PEW. However, this can be influenced by diet, 
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exercise, fat mass, and hydration status and may not be pathological in certain racial-ethnic 
groups [5, 27]. In a recent meta-analysis, it was confirmed that patients with PD who presented 
with low weight compared to the ranges of overweight and obesity had an increased risk of 
mortality [28]. The expert panel also recommends that the unintentional loss of 5% of non-
edematous weight within 3 months or an unintentional loss of 10% of non-edematous weight 
over the past 6 months should be considered an indicator of PEW [5]. Even still, the majority of 
PD patient cases experience a significant gain in body weight [29]. The presence of weight loss 
in the first year is associated with adverse results [30, 31]. One limitation for the assessment of 
this parameter is the fluid gain that can mask weight loss [27]. The third measure that can be 
considered for the diagnosis of PEW is a low percentage of body fat, but the specificity of this 
criterion is questionable in persons who are very muscular and athletic [5, 27].
4.1.3. Muscle mass
The reduction of muscle mass appears to be the most valid criterion for the presence of PEW [5]. 
Methods like the dual-energy X-ray absorptiometry and bioelectrical impedance analysis have 
Criteria
Serum chemistry
Serum albumin (<3.8 g/dL (bromocresol green)a)
Serum prealbumin (transthyretin) (<30 mg/dL (for maintenance dialysis)a)
Serum cholesterol (<100 mg/dLa)
Body mass
BMI (<23b)
Unintentional weight loss over time (5% over 3 months or 10% over 6 months)
Total body fat percentage (<10%)
Muscle mass
Muscle wasting: reduced muscle mass (5% over 3 months or 10% over 6 months)
Reduced MAMCc (reduction >10% in relation to 50th percentile of reference population)
Creatinine appearanced
Dietary intake
Unintentional low dietary protein intake (<0.80 g/kg/day for at least 2 monthse for dialysis patients)
Unintentional low dietary energy intake (<25 kcal/kg/day for at least 2 monthse)
At least three out of the four listed categories (and at least one test in each of the selected categories) must be satisfied for 
the diagnosis of kidney disease-related PEW.
Optimally, each criterion should be documented on at least three occasions, preferably 2–4 weeks apart.
aNot valid if low concentrations are due to abnormally great urinary or gastrointestinal protein losses, liver disease, or 
cholesterol-lowering medicines.
bA lower BMI might be desirable for certain Asian populations; weight must be edema-free mass.
cMeasurement must be performed by a trained anthropometrist.
dCreatinine appearance is influenced by both muscle mass and meat intake.
eCan be assessed by dietary diaries and interviews or for protein intake by calculation of normalized protein equivalent 
of total nitrogen appearance (nPNA or nPCR) as determined by urea kinetic measurements.
Table 2. Criteria for the clinical diagnosis of PEW in CKD.
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been used to assess the loss of muscle mass in PD patients [32–34]. The increase in risk of mor-
tality has been observed with the loss of muscle mass assessed through these types of methods 
[35, 36]. The reduction in MAMC is another recommended criterion for the diagnosis of PEW 
[5], and the anthropometric parameters, including the MAMC, have been demonstrated to 
identify low muscle mass in these patients [37]. However, this method can be insensitive since 
it is associated with a substantial interobserver error and the volume state [7]. Equations based 
on the MAMC and handgrip strength have been favorably correlated with muscle mass [38].
4.1.4. Dietary intake
A decrease in appetite (anorexia) can be associated with PEW. Therefore, the unintentional 
reduction of protein intake <0.80 g per kg of body weight per day and an unintentional reduc-
tion in energy intake of <25 kcal per kg of body weight per day for at least 2 months have 
been proposed as an indicator of PEW [5]. Dietary intake can be assessed by dietary dia-
ries and interviews or for protein intake by calculation of normalized protein equivalent of 
total nitrogen appearance (nPNA or nPCR) as determined by urea kinetic measurements [5]. 
One important aspect to consider is the obligatory absorption of glucose with PD, since it 
can result in an absorption of carbohydrates on average of approximately 400 kcal of energy 
intake every day, and so estimating the total daily energy intake derived from the sum of the 
diet and the dialysate could be adequate for the diagnosis of PEW [39].
4.2. Subjective global assessment
The SGA is a tool that is used to assess the nutritional status, and it has been validated for use 
in PD patients [18, 40–42]. The increase in risk of mortality has been confirmed with the pres-
ence of PEW assessed by this tool [12, 43]. The SGA is composed of a medical history and a 
physical examination (Figure 1). In each component a score is assigned based on a scale from 
1 to 7, with lower values representing worse nutritional status. The medical history includes 
weight change (the last 2 weeks, as well as the previous 6 months), dietary intake, gastroin-
testinal symptoms, functional capacity, and the disease state and comorbidities. The physical 
exam includes the loss of subcutaneous fat (below the eye, triceps, biceps, chest), muscle wast-
ing (temple, clavicle, scapula, ribs, quadriceps, calf, knee, interosseous), and edema. When 
this examination has been completed, an overall SGA rating is assigned to the patient and 
ranges from a rating of 1–2 for severe PEW, 3–5 for mild-moderate PEW, and 6–7 for very mild 
PEW to well-nourished [17, 40].
4.3. Malnutrition-inflammation score
Upon recognizing the role that inflammation plays in the pathogenesis of PEW, a more com-
prehensive, quantitative scoring system was created called the MIS, which utilizes a revised 
form of the SGA scoring system and adds BMI, serum albumin, and the binding capacity of 
iron or transferrin [17, 18, 44]. The MIS has 10 components, each one with four levels of sever-
ity, from 0 (normal) to 3 (severely abnormal) (Figure 2). The sum of all 10 MIS components 
ranges from 0 (normal) to 30 (severe PEW); a higher score reflects a more severe degree of 
PEW and inflammation [44]. The MIS assessment has been identified as a predictor of mor-
bidity and mortality in PD patients [45, 46]. Also, diverse authors have observed a reasonable 
correlation of the MIS with the SGA in this population [47, 48].
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4.4. Geriatric nutritional risk index
The GNRI was proposed using the argument that because current methods of nutritional assess-
ment use several subjective assessments and judgments, assessment by a well-trained staff is nec-
essary to obtain consistent results between the different examiners and institutions. Furthermore, 
Figure 1. Seven-point scale SGA.
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these methods are somewhat time-consuming and cumbersome. The GNRI was developed with 
the intention of being the simpler method to assess nutritional status in which only three objec-
tive parameters are used: body weight, height, and serum albumin levels (Table 3) [18]. It has 
been observed that the GNRI is related to diverse nutritional parameters including the MIS, SGA, 
Figure 2. Components of the malnutrition-inflammation score (MIS).
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BMI, creatinine, albumin, arm circumference, and fat mass index, as well as being associated with 
greater mortality in PD patients [9, 49]. This makes the GNRI a simple method to predict nutri-
tional status and the clinical results in these patients [49].
4.5. Clinical scenario for the diagnosis of protein-energy wasting in peritoneal 
dialysis
4.5.1. Case 1
A 27-year-old male with PD for 36 months who attending to the nephrology service in order 
to perform a peritoneal equilibrium test, wich results in a low-average transport.
Baseline weight 64.5 kg, current weight 64.5 kg, height 1.75 m, BMI 21.06 kg/m2, ideal body 
weight 70.5 kg, MAMC 21.51 cm (reduction >10%), percentage of body fat 13.52, energy intake 
742 kcal (10.52 kcal/kg per day), and protein intake 28 g (0.39 g/kg per day).
Laboratory measurements: hemoglobin 7.64 g/dL, total lymphocyte count 900 cells/mm3, glu-
cose 85 mg/dL, creatinine 18.75 mg/dL, BUN 79.80 mg/dL, P 8.10 mg/dL, Ca 8.7 mg/dL, Cl 
100 mmol/L, K 4.90 mmol/L, Na 140 mmol/L, Mg 3.30 mg/dL, albumin 3.00 g/dL, total pro-
teins 5.7 g/dL, cholesterol 139 mg/dL, and transferrin 256.5 mg/dL.
Based on these data, which of the following diagnostic criteria meet for PEW (Table 2)?
(A) Cholesterol, percentage of body fat, and MAMC
(B) Albumin, BMI, and MAMC or protein/energy intake
(C) Albumin, unintentional weight loss, and percentage of body fat
4.5.2. Case 2
An 18-year-old male with PD for 13 months who is hospitalized in our service for the presence 
of abdominal pain at the time of the replacement dialysis solutions is diagnosed with peritonitis 
and Pseudomonas aeruginosa, which were isolated.
Baseline weight 55 kg, current weight 44.7 kg, height 1.60 m, BMI 17.46 kg/m2, ideal body 
weight 59 kg, MAMC 19.61 cm, and percentage of body fat 8.3. The medical history shows 
an unintentional weight loss of 18.73% in the last 6 months, as well as an inadequate calorie 
intake of 1075 kcal (18.22 kcal/kg per day) and a protein intake of 56.5 (0.95 g/kg per day). 
Anorexia, nausea, vomiting, and diarrhea were not present. In terms of functional capacity 
with loss, rarely gets out of bed and does so with help for <2 weeks and in the state of the dis-
ease and comorbidities, presents an increase in nutritional requirements and high metabolic 
stress due to the presence of peritonitis. The physical exam shows a severe loss of subcutane-
ous fat and muscle wasting in all areas, without the presence of edema.
Formula
GNRI = [14.89 × albumin (g/dL)] + [41.7 × (body weight/ideal body weight)]
Table 3. Geriatric nutritional risk index (GNRI).
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Laboratory measurements: hemoglobin 6.48 g/dL, total lymphocyte count 670 cells/mm3, glu-
cose 65 mg/dL, creatinine 9.91 mg/dL, BUN 53.30 mg/dL, P 3.90 mg/dL, Ca 9.92 mg/dL, Cl 
92 mmol/L, K 3.90 mmol/L, Na 132 mmol/L, Mg 1.90 mg/dL, albumin 2.10 g/dL, total proteins 
4.7 g/dL, cholesterol 115 mg/dL, and transferrin 98.4 mg/dL.
Based on these data, what overall SGA rating presents this patient (Figure 1)?
(A) 6–7 Very mild PEW to well-nourished
(B) 3–5 Mild–moderate PEW
(C) 1–2 Severe PEW
4.5.3. Case 3
A 36-year-old female with PD for 60 months who is hospitalized for the presence of abdomi-
nal pain, constipation, nausea and vomiting is diagnosed with peritonitis and Staphylococcus 
haemolyticus, which were isolated.
Baseline weight 62 kg, current weight 51.2 kg, height 1.55 m, ideal body weight 55 kg, MAMC 
21.95 cm, and percentage of body fat 21.39.
In the medical history component, there is evidence of an unintentional weight loss of 17.42% in 
the last 6 months, as well as an inadequate calorie intake of 630 kcal (11.45 kcal/kg per day) and 
a protein intake of 21.1 gr (0.38 g/kg per day). Also presenting gastrointestinal symptoms like 
nausea every day >2 weeks and vomiting every day <2 weeks. In the functional capacity, pres-
ents difficulty with independent activities, and as the only comorbidity, the time in dialysis of 
5 years. The physical exam shows a moderate loss of subcutaneous fat in the triceps and biceps, 
as well as a moderate muscle wasting in the interosseous, temples, clavicles, and quadriceps. 
With a calculated BMI of 21.31 kg/m2 and laboratory parameters with albumin 2.00 g/dL and 
transferrin 128 mg/dL.
Other laboratory measurements: hemoglobin 9.41 g/dL, total lymphocyte count 670 cells/
mm3, glucose 78 mg/dL, creatinine 9.41 mg/dL, BUN 27.57 mg/dL, P 4.60 mg/dL, Ca 9.42 mg/
dL, Cl 91 mmol/L, K 3.50 mmol/L, Na 130 mmol/L, Mg 1.60 mg/dL, total proteins 5.1 g/dL, 
and cholesterol 152 mg/dL.
Based on the 10 components of the MIS, what score does this patient present (Figure 2)?
(A) 22
(B) 29
(C) 15
4.5.4. Case 4
A 32-year-old male with PD for 74 months who attending to the nephrology service in order 
to perform a peritoneal equilibrium test, wich results in a high-average transport.
Baseline weight 55 kg, current weight 55 kg, height 1.62 m, BMI 20.95 kg/m2, ideal body weight 
60.5 kg (ideal body weight = ([BMI = 23 kg/m2] x height2), MAMC 19.68 cm, percentage of body 
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fat 21.07, energy intake 1380 kcal (22.80 kcal/kg per day), and protein intake 52 g (0.85 g/kg 
per day).
Laboratory measurements: hemoglobin 7.63 g/dL, total lymphocyte count 1460 cells/mm3, 
glucose 97 mg/dL, creatinine 10.27 mg/dL, BUN 40.90 mg/dL, P 3.30 mg/dL, Ca 8.7 mg/dL, Cl 
101 mmol/L, K 4.40 mmol/L, Na 139 mmol/L, Mg 1.90 mg/dL, albumin 2.00 g/dL, total pro-
teins 5.6 g/dL, cholesterol 135 mg/dL, and transferrin 138.1 mg/dL.
Based on this data, which of the following ranges of IRNG does this patient present (Table 3)?
(A) 92.91
(B) 67.68
(C) 72.93
5. Prevention of protein-energy wasting
Diverse factors can affect the nutritional and metabolic status of patients with CKD, for which 
they require interventions to prevent or reverse protein and energy depletion. Preventive 
measures include continuous nutritional counseling, optimizing dietary nutrient intake, renal 
replacement therapy, and management of the different comorbidities (metabolic acidosis, dia-
betes mellitus, congestive heart failure, depression) [50].
5.1. Nutritional counseling
Nutritional counseling can be a useful tool in PD patients in order to improve compliance 
with nutritional recommendations [51]. The minimum recommendations in order to prevent 
inadequate nutrient intake in these patients is presented in Table 4 [50]. In a prospective study 
with 258 PD patients, individualized nutritional counseling significantly improved calorie 
and protein intake, the BMI, and the PEW [14]. However, despite this type of intervention, 
it has been observed that not all patients achieve an optimal nutrient intake [14, 52]. In our 
population, although nutritional counseling has been shown to not significantly improve all 
of the nutritional parameters, it is capable of maintaining the nutritional status despite the 
decrease in residual kidney function and the presence of systemic inflammation [53]. The 
Kidney Disease Outcomes Quality Initiative (K/DOQI) Guidelines recommend that nutri-
tional counseling should be intensive initially and provided thereafter every 1 or 2 months 
and more frequently if inadequate nutrient intake or PEW is present or if adverse events or 
illnesses occur that may cause deterioration in nutritional status [54].
5.2. Optimize dietary nutrient intake
Optimizing the dietary nutrient intake is one strategy that can improve calorie and pro-
tein intake [50]. The suggestion of individualized menus and the list of interchangeable 
foods in equivalent quantities have been demonstrated to improve the achievement of 
protein intake in PD patients [55]. The increased protein requirement (>1.2 g/kg/day) in 
these patients makes them subject to a higher phosphorus load; thus, the reduced intake of 
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phosphorus without depriving protein intake should be centered in food choices with a 
lower quantity of phosphorus per gram of protein (e.g., egg whites) and in those choices 
that have lower intestinal absorption (vegetables) [56]. The reduction in sodium intake is 
another commonly prescribed strategy to maintain volume state [57]. It has been observed 
that patients with a low sodium intake are associated with nutrient deficits, poor mus-
cle protein stores, and worse results [58]. Therefore, measures to reduce dietary sodium 
through the use of flavor enhancers, and preparing a diet with 2 g of sodium (88 mM NaCl) 
adding 1/3 teaspoon of salt to each meal throughout the day, could help to avoid nutri-
tional deficits [57, 59].
5.3. Renal replacement therapy
The dialysis adequacy has long been considered a measure for the prevention and treatment 
of PEW in patients who undergo maintenance dialysis, and a minimum dose of dialysis has 
been recommended to maintain optimal dietary nutrient intake [50]. A 25% increase in PD 
volume has been shown to improve calorie intake and stabilize the mid-arm circumference, 
protein nitrogen appearance, and SGA in PEW patients [60]. However, in the ADEMEX study, 
significant differences were not observed between the nutritional markers (nPNA, body 
weight, prealbumin) with the increase in the dose of PD to 60 l/week [61]. Therefore, it can 
be concluded that what is actually considered an adequate dialysis in different guidelines is 
sufficient to preserve the nutritional status [50].
5.4. Comorbidities
Diverse comorbidities associated with ESRD contribute to a catabolic milieu and the develop-
ment of PEW [6]. Metabolic acidosis increases muscle protein catabolism via suppression of 
the insulin/insulin growth factor-1 signaling and the activation of the ubiquitin-proteasome 
system [50]. In PD patients, correction of the serum level of bicarbonate has demonstrated 
downregulation of branched-chain amino acid degradation and muscle proteolysis [62]. 
Protein >1.2 g/kg/day
Peritonitis >1.5 g/kg/day
Energy 30–35a kcal/kg/day including kcal from dialysate
Sodium 80–100 mmol/day
Potassium Not usually an issue
Phosphorus 800–1000 mg and binders if elevated
Greater than 50% of high biological value protein (i.e., complete protein sources, containing the full spectrum of essential 
amino acids) is recommended.aBased on the physical activity level. In sedentary elderly adults, recommended energy 
intake is 30 kcal/kg/day.
All recommendations are based on ideal body weight. Regular follow-up supports compliance.
Table 4. Recommended minimum protein, energy, and mineral intakes for peritoneal dialysis patients by the ISRNM.
Evolving Strategies in Peritoneal Dialysis76
Other studies have reported an improvement in the nutritional status with the correction 
of the metabolic acidosis through an increase in the body weight, mid-arm circumference, 
SGA score, and the nPNA [63, 64]. Diabetes mellitus is one of the most frequent comorbidi-
ties in patients with CKD [6], and PEW is more prevalent in diabetic PD patients compared 
to nondiabetics [65, 66]. The degree of insulin resistance and/or insulin deprivation seems 
to develop this condition [50]. Therefore, the adequate management of diabetes and insulin 
resistance is important in preventing further loss of lean body mass in patients undergoing 
maintenance dialysis. This is especially relevant for PD patients because of the exposure to 
around 80–330 g of additional glucose from the dialysate [50]. Inflammation is frequent in PD 
patients and is associated with PEW, peritoneal membrane dysfunction, and cardiovascular 
events [67]. The increase in systemic concentrations of proinflammatory cytokines is thought 
to play an integral role in the muscle catabolism of patients with ESRD. Interleukin-6 causes 
an increase in muscle proteolysis, and the tumor necrosis factor-alpha can cause anorexia 
through its effects on the satiety center in the central nervous system [68]. Strategies that can 
reduce inflammation include the control of infectious processes, optimizing the prescription 
of PD (improving the volume state, biocompatible solutions), pharmacological interventions 
(statins, angiotensin-converting enzyme inhibitors, sevelamer), and nutritional interventions 
(antioxidants) [69]. Another common comorbidity is congestive heart failure [6]. In these 
patients the circulatory congestion has been associated with a reduction in the protein and 
calorie intake, greater inflammation, PEW, and the increase in resting energy expenditure 
[70]. Other disorders like uncontrolled hyperparathyroidism and cardiac cachexia are asso-
ciated with systemic inflammation and the increase in energy expenditure [50]. The symp-
toms of depression, which are common in ESRD patients, are related to fatigue, the lack of 
appetite, and weight loss. Early recognition and treatment are important components in the 
prevention of PEW [68].
6. Treatment of protein-energy wasting
For patients in whom the standard preventative measures are unable to diminish the loss 
of protein and energy stores, nutritional supplementation should be initiated through oral, 
intraperitoneal, enteral, or parenteral routes. Anabolic agents, appetite stimulants, anti-
inflammatory interventions, and exercise can be utilized as adjuvant therapies [50].
6.1. Oral nutritional supplementation
Oral supplementation can provide an additional 7–10 kcal/kg per day of energy and 0.3–0.4 g/
kg per day of protein. This requires a minimum spontaneous dietary intake of 20 kcal/kg per 
day of energy and 0.4–0.8 g/kg per day of protein in order to meet the recommended dietary 
energy intake and dietary protein intake targets [50, 68]. Oral nutritional supplements have 
been shown to improve protein-calorie intake and the nutritional status (body weight, preal-
bumin, SGA score) in PD patients [71, 72]. However, a high rate of non-compliance and intol-
erance has been reported with the long-term use of these types of supplements [73]. Other 
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studies have demonstrated that supplementation with calcium caseinate and egg albumin 
increases levels of serum albumin and nutrient intake [74, 75]. When considering the use of 
these supplements, in addition to the type and quantity to use, one must also take into consid-
eration the baseline nutritional status, dietary intake, patient preference, acceptance, willing-
ness to use and to purchase the supplements, tolerance and contraindications, and duration 
of use in the care plan [76].
6.2. Intraperitoneal nutritional supplementation
PD patients lose 3–4 g/day of amino acids (AAs) and 4–15 g/day of proteins [77, 78]. One 
exchange with a 1.1% AA dialysis solution has been demonstrated to be sufficient to com-
pensate for these losses [78]. In patients with PEW, the treatment with AA in the nitro-
gen balance dialysate became significantly positive, and there was a significant increase 
in net protein anabolism, the fasting morning plasma amino acid pattern became more 
normal, and serum total protein and transferrin concentrations rose [79]. In another long-
term study, improvements in some nutritional parameters including the nPNA, lean body 
mass, and handgrip strength have been observed [80]. In general, it is recommended to 
use one bag of AA dialysate in place of one glucose-based dialysate. Using more than 
one bag during a 24-h period runs the risk of increasing the level of urea nitrogen and 
decreasing levels of bicarbonate [39]. Overall, AA dialysate remains a viable option in 
PD patients with PEW who cannot tolerate or are not suitable for PO (per oral) and other 
enteral supplements [50].
6.3. Enteral nutritional supplementation
Enteral nutrition has been poorly investigated in PD patients [81]. Considerations for its use 
include the lack of improvement in nutritional status despite the use of oral nutritional sup-
plements, the presence of severe PEW, spontaneous intake of <20 kcal/day, or conditions of 
stress [82]. Enteral nutrition can be administered via nasogastric feeding [51]. The use of per-
cutaneous endoscopic gastrostomy or percutaneous endoscopic jejunostomy has been contra-
indicated in these patients due to the increase in the incidence of peritonitis [81]. However, 
there have been some reports of cases where the percutaneous endoscopic gastrostomy can 
be an effective nutritional strategy [83–85]. The feeding formulas with a higher protein but 
lower carbohydrate content are to be preferred. Products rich in proteins should be used as 
oral nutritional supplements [81].
6.4. Parenteral nutritional supplementation
Parenteral nutrition has also been poorly investigated in PD patients [82]. It has been sug-
gested that its initiation should be limited to patients with PEW and those who are stressed, 
or in patients with severe encapsulating peritonitis, when the nutritional requirements cannot 
be ensured through oral or enteral routes [82]. Early parenteral nutrition has been shown to 
maintain a positive nitrogen balance in peritonitis [86]. As well, in patients with encapsulating 
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peritoneal sclerosis, the parenteral nutritional support seems to be better than enteral nutrition 
[87, 88]. During parenteral nutrition the energy supply should combine carbohydrate and lipid. 
The use of specific formulas for parenteral mixtures is not yet supported by controlled data [82].
7. Adjuvant therapies
Diverse adjunctive therapies can be used to treat PEW in these patients. The use of anabolic 
hormones results in a positive nitrogen balance, an increase in lean body mass, and improve-
ment in the anthropometric parameters [89–91]. Appetite stimulants can have favorable 
effects on body weight, appetite, and calorie intake [92, 93]. When comorbidities and poten-
tial dialysis-related causes of inflammation have been assessed and appropriately treated, 
other anti-inflammatory treatment strategies such as anti-oxidative and/or bioecologic strate-
gies or targeted anti-cytokine therapies could be considered in patients who are persistently 
inflamed [68]. On the other hand, PD patients have low levels of physical activity, which 
can be associated with PEW [94, 95]. Progressive resistance exercise induces skeletal muscle 
hypertrophy, increases muscular strength, and improves the health-related quality of life [96]. 
This is important since exercise interventions can prevent or reverse PEW [97].
8. Conclusions
PEW is very frequent in PD patients and is associated with mortality. Assessment and moni-
toring of the nutritional status are important to diagnose, prevent, and treat PEW. Large-scale 
clinical trials and international collaborations that refer to the effects of nutritional interven-
tions on PEW are necessary in order to advance on this subject. Meanwhile, individualizing 
the different interventions for prevention and treatment of PEW proposed in this chapter 
should be employed in PD patients.
Clinical scenario responses for the diagnosis of protein-energy wasting in peritoneal dialysis:
Case 1 = (B) Albumin, BMI, and MAMC or protein/energy intake.
Case 2 = (C) 1–2 Severe PEW.
Case 3 = (A) 22.
Case 4 = (B) 67.68.
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